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Summary, general discussion and future perspectives
SuMMARy
The population of patients with advanced chronic kidney disease has largely become 
a geriatric population. Life expectancy has increased and chronic diseases including 
chronic kidney disease are more common in elderly individuals. Therefore, both the 
prevalence of advanced chronic kidney disease as well as the incidence of elderly 
starting dialysis therapy has grown the past years. In fact, chronic kidney disease itself 
is considered a model of accelerated aging. Geriatric syndromes are often present in 
older adults with advanced chronic kidney disease. The general aim of this thesis was to 
provide a geriatric perspective on chronic kidney disease. More specifically, we studied 
consequences of advanced chronic kidney disease on the three M’s: muscle, mobility 
and mind.
PART I - Muscle 
Low BMI could be an indicator of low muscle mass. Contrary to general and other chronic 
disease populations, low BMI was not associated with an excess risk of mortality in a 
study of incident dialysis patients. 1 Mortality and cardiovascular event rates in dialysis 
patients are especially high in the first period after the initiation of dialysis. Therefore, 
we hypothesized that the effect of low BMI on survival might be different for the short 
versus longer-term, and in Chapter 2 we studied possible time-dependent effects of low 
BMI in incident dialysis patients. Our main finding was that lower BMI conferred a higher 
mortality risk on the short-term (i.e. <1 year after dialysis initiation), whereas it was as-
sociated with a lower mortality on the long term, (i.e. >1 year after dialysis initiation). 
Furthermore, patients with lower BMI who died during the first year had significantly 
more comorbidity and worse self-reported physical functioning compared with those 
who survived the first year. Although we did not perform a prediction study, our results 
suggest that besides lower BMI, mobility and functional (in)dependence, low albumin 
levels, and comorbidities including diabetes mellitus, heart failure, and peripheral vas-
cular disease should be included in prediction scores of short-term mortality.
Next, we refined our research on body composition and outcomes in chronic kidney 
disease to a more specific muscle marker. To this end, we used creatinine synthesis rate, 
which was measured by determining the 24-hour urinary creatinine excretion, as a proxy 
of muscle mass. In Chapter 3, we first defined reference values of low urinary creatinine 
excretion using a large healthy subsample of the general-population based PREVEND 
study. Low urinary creatinine excretion, indexed for height, was defined as below the 
age- and sex-specific 5th percentile of the distribution in the healthy PREVEND sample. 
Subsequently, we applied this definition to a cohort of patients with advanced chronic 
kidney disease. For this cohort we included patients with chronic kidney disease stage 4 
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(i.e. estimated glomerular filtration rate, eGFR <30ml/min/1.73m2) or stage 5 (eGFR <15 
ml/min/1.73m2), not yet on dialysis, from the PREPARE-2 and NECOSAD cohorts. Apply-
ing this definition, we found that 38% of the advanced chronic kidney disease patients 
had a low urinary creatinine excretion. The strongest correlate of low urinary creatinine 
excretion was a lower kidney function. Second, we studied the association between low 
urinary creatinine excretion and self-reported frailty. We found that self-reported frailty 
was associated with low urinary creatinine excretion, independent of comorbidities. 
This was also true for all the individual components that define self-reported frailty, and 
the frailty-associated variables hemoglobin, albumin, and parathyroid hormone. As we 
expected, further adjusting of the models for glomerular filtration rate attenuated most 
associations with the individual frailty components. This finding suggests that reduced 
glomerular filtration rate, and thus chronic kidney disease and the complications of 
chronic kidney disease, might lead to muscle wasting, both directly and indirectly via 
weakness, slowness, physical inactivity, and exhaustion. 
The findings of our previous study led to the new hypothesis that urinary creatinine 
excretion might not only be a reflection of muscle mass, but also of muscle function and, 
more in general, of physical function. In Chapter 4 we investigated this hypothesis by 
studying associations between creatinine synthesis rate and muscle strength and self-
reported measures of physical health in dialysis patients. For this study, total dialysate 
was collected to measure creatinine removal by the dialysis procedure, plus urinary 
creatinine excretion, in patients with residual renal function. Indeed, we found that 
higher creatinine synthesis rate was associated with higher handgrip strength in men 
and women. Furthermore, a higher creatinine synthesis rate was associated with better 
self-reported physical functioning, vitality, and physical activity, and with less fatigue 
and role limitation due to physical health. Thus, we concluded that creatinine synthesis 
rate reflects muscle function and self-reported physical health in dialysis patients.
PART II - Mobility
Geriatric syndromes or the so-called ‘Geriatric Giants’ are those clinical conditions in 
older persons that do not ﬁt into one specific disease category. In Chapter 5 we studied 
falls, a ‘Geriatric Giant’ that forms an important problem in older adults. We aimed to 
determine the incidence, complications and risk factors for falls in an elderly dialysis 
population. Our study showed that 55% of the patients aged ≥70 years fell at least once 
during a 1-year follow-up. Falls resulted in fractures in 15% of cases and in hospital 
admissions in 15% of patients. A lower systolic blood pressure before hemodialysis and 
a higher parathyroid hormone plasma concentration were identified as risk factors for 
falling. This study underscores that falls are an important health problem with adverse 
consequences in older adult dialysis patients, and therefore need the attention of ne-
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phrologists. Multifactorial fall prevention strategies can be applied to reduce the fall and 
thus complication risk.
PART III - Mind 
Cognitive impairment is highly prevalent in patients with advanced chronic kidney 
disease. Interestingly, the transition to dialysis has been associated with an accelerated 
decline in cognitive functioning. Similar to myocardial perfusion, which declines during 
hemodialysis, we hypothesized that hemodialysis would also reduce brain perfusion. In 
Chapter 6 we reported the findings of our study on the acute effect of hemodialysis on 
cerebral blood flow, as measured by [15O]H2O positron emission tomography (PET) scan-
ning. In agreement with our hypothesis, we found that hemodialysis led to a reduction in 
global and in regional cerebral blood flow as measured in the frontal, parietal, temporal, 
and occipital lobe, and the cerebellum and thalamus. Hemodialysis-related factors that 
were associated with a lower cerebral blood flow were a higher pH, a higher tympanic 
temperature, and a larger ultrafiltration volume and rate. These findings warrant follow-
up research on the effects of modification of the dialysate bicarbonate concentration 
and of lowering the ultrafiltration rate by performing longer hemodialysis sessions on 
the preservation of cerebral blood flow during hemodialysis. 
In Chapter 7 we studied whether near-infrared spectroscopy would be an alternative 
method to detect changes in cerebral blood flow, because [15O]H2O PET-scanning in-
volves radiation, requires an on-site cyclotron for nuclide generation, and is complicated 
to perform during a hemodialysis session. To this end, we estimated ΔrSO2 as the change 
in frontal regional oxygen saturation from before start of hemodialysis to the end of 
hemodialysis, as measured by near-infrared spectroscopy. Furthermore, we estimated 
ΔCBF as the change in frontal gray matter cerebral blood flow from before the start of 
hemodialysis to the end of hemodialysis, as measured by PET. In this study we found 
that the correlation between frontal ΔrSO2 and ΔCBF was moderate, although NIRS 
tended to underestimate ΔCBF. Furthermore, considerable differences were noted with 
regard to associations of hemodialysis- and oxygenation-related factors and markers of 
endothelial activation with rSO2 as compared to cerebral blood flow. Thus, near-infrared 
spectroscopy could be used to detect intradialytic CBF declines, although some correc-
tion factor may be needed. Furthermore, the different associations of hemodialysis- and 
oxygenation-related factors and markers of endothelial activation with rSO2 as com-
pared to cerebral blood flow underscore that NIRS and PET capture different physiologi-
cal parameters of the brain. Future studies are needed to evaluate the consequences of 
large intradialytic rSO2 declines on brain ischemia and cognitive functioning. 
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GENERAl dISCuSSION ANd FuTuRE PERSPECTIvES
This thesis addresses consequences of advanced chronic kidney disease on muscle, 
mobility and mind. In the Discussion and Future perspectives, we will not only focus on 
the three individual M’s, but also speculate on how the three M’s are interconnected. 
Next, we will consider several interventions that might improve muscle, mobility and 
mind and, finally which future research is needed in patients with advanced chronic 
kidney disease. 
Identifying low muscle mass and strength in chronic kidney disease
Loss of muscle mass and of muscle strength are prevalent conditions in patients with 
chronic kidney disease. Consequences of loss of muscle mass and strength such as frailty, 
falls, immobility, loss of independence and quality of life, and ultimately mortality, that 
were reported in the general population 2-5 have also been demonstrated in the chronic 
kidney disease population. 6-11 With those consequences in mind, identification of pa-
tients with reduced muscle mass and strength is important. Although muscle strength 
could be easily measured, e.g. by using a hand dynamometer, this is rarely performed in 
clinical practice. Furthermore, consensus is lacking on the method to assess muscle mass 
in chronic kidney disease patients. This thesis provided an alternative definition of low 
muscle mass, by using a simple regression equation that defines low urinary creatinine 
excretion or low creatinine synthesis rate according a healthy population. The equa-
tion needs future validation in an external cohort and requires comparison with other 
techniques for low muscle mass identification (e.g. dual-energy X-ray absorptiometry). 
Creatinine synthesis rate as a marker to monitor muscle and physical 
functioning
Besides identifying patients with low muscle mass, creatinine synthesis rate might also 
be an easy applicable biomarker to detect declines in muscle mass and function, and 
physical functioning more in general, in patients with advanced chronic kidney disease. 
This thesis showed that creatinine synthesis rate was associated with self-reported 
frailty, and frailty-associated determinants in patients with advanced chronic kidney dis-
ease, and with muscle strength, and self-reported physical functioning, vitality, physical 
activity, fatigue, and role limitation due to physical health in dialysis patients. Creatinine 
synthesis rate is regularly estimated in non-dialysis chronic kidney disease patients, by 
measuring creatinine excretion in 24-hour urine samples. Nephrologists can take notice 
of the creatinine synthesis rate not only for the estimation of creatinine clearance by 
the kidney, but also as a proxy to assess (changes in) muscle mass and function. In 
peritoneal dialysis treatment, patients regularly collect all the spent dialysate during 
24 hours, and, if applicable, also urine to estimate dialysis treatment adequacy. Thus, 
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adding estimation of creatinine synthesis rate based on 24-hour dialysate and urine col-
lections is relatively easy to perform. In hemodialysis patients, estimation of creatinine 
synthesis rate by measurement of creatinine excretion in the dialysate and, if applicable, 
also in the urine, is relatively easy to perform. Thus, due to its easy availability, creatinine 
synthesis rate estimation is a low-cost method, especially compared to dual-energy 
X-ray absorptiometry, computed tomography or MRI. Nevertheless, future research is 
needed to investigate the use of creatinine synthesis rate for monitoring muscle and 
physical health, and to study whether declines in creatinine synthesis rate are associated 
with adverse outcomes. 
Falls in dialysis patients
This thesis showed a high incidence of falls of 55% during 1-year follow-up in elderly 
dialysis patients, which is considerably higher than the one-year incidence of 32-41% 
that was reported in community-dwelling elderly aged ≥80 years. 12-15 In addition to the 
effects of chronic kidney disease on muscle and mobility, the dialysis procedure itself 
might have direct effects on muscle and mobility as well. It was reported that patients 
were slower to get out of their chair, had lower muscle strength, worse postural instabil-
ity, and needed more time to perform the timed-up-and-go time test post-hemodialysis 
as compared to pre-hemodialysis. 16-18 Although it has often been hypothesized that 
hemodialysis patients would fall more frequently than peritoneal dialysis patients due 
to rapid fluid shifts during hemodialysis, recent studies showed that both have similar 
fall rates. 19, 20 Especially the period just after dialysis initiation, whether hemodialysis or 
peritoneal dialysis, might yield a large fall risk. A study among patients aged ≥67 years 
showed high rates of serious fall injuries both before and after hemodialysis therapy 
initiation. 21 Notably, the risk for a serious fall injury was 1.6-fold higher in the period 
after versus before hemodialysis initiation. Despite the overall lower monthly fall rates in 
peritoneal dialysis patients, the risk for a serious fall injury increased significantly after 
initiation of peritoneal dialysis and was even 4.1-fold higher in the period after versus 
before dialysis initiation.21
Mobility and falls in early chronic kidney disease 
It is more and more acknowledged that negative effects on physical ability and mobility 
are already present in the early stages of chronic kidney disease. Several large general 
population cohort studies reported associations between lower kidney function and 
gait impairment, slower gait speed, and lower muscle strength. 22-24 In addition, another 
study reported a strong and potentially causal relation between chronic kidney disease 
and declining mobility. In that study, metabolites of kidney function were associated 
with incident mobility disability. 25 Mobility disability, gait impairment and loss of muscle 
mass and function are all predisposing factors for falls. As a result, fall accidents in pa-
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tients with chronic kidney disease are not limited to those with advanced stage chronic 
kidney disease or those receiving dialysis therapy. In a cohort of community-dwelling 
older adults, the risk for serious fall injuries increased with higher levels of albuminuria. 
26 Albuminuria, arising because of glomerular capillary leak and primarily caused by 
kidney microangiopathy, has been independently associated with cerebral small ves-
sel disease, e.g. white matter hyperintensities, lacunar infarcts and microbleeds. 27 An 
extensive  body of evidences suggests that white matter hyperintensities are associ-
ated with gait disturbances, mobility and falls, 28-32 thus potentially explaining the link 
between albuminuria and fall accidents.  
Fall prevention strategies in dialysis patients
A fall is often a life-changing event, the start of a downward spiral of decreasing physi-
cal functioning, dependency, and loss of quality of life. Given the complexity of falls 
and the interaction between many predisposing and precipitating factors, reduction 
of falls by applying a single intervention is an illusion. Fall prevention strategies need 
to be multifactorial, e.g. targeting balance and gait abnormalities, visual impairment, 
environmental factors, medication adverse effects, and patient and caregiver education. 
In independently living older adults, multifactorial and exercise interventions were 
shown to be effective in reducing the number of fallers, the frequency of falls, and, or 
fall-related injuries. 33-36 Yet, the evidence was reported to be most consistent across 
multiple fall-related outcomes for exercise. 33 Theoretically, fall prevention strategies in 
dialysis patients will be more effective if they also address specific dialysis-related fall 
risk factors, besides the traditional fall risk factors. Fall risk factors that were identified 
by this thesis and previous studies in dialysis patients include, but are not limited to, 
orthostatic hypotension, lower systolic blood pressure before dialysis, older age, frailty, 
antidepressants use, number of medications, comorbidities, ore specifically diabetes, a 
previous fall, malnutrition, higher parathyroid hormone, and (self-reported) frailty. 37-45 
Currently, only one study examined fall prevention strategies in dialysis patients, limited 
to a dialysis center. 46 This study reported that after an interventional period, which in-
cluded formal staff education, implementation of a fall risk assessment tool, active and 
passive patient education programs, and environmental modifications in the dialysis 
center, a remarkable reduction in falls was observed. Nevertheless, this thesis showed 
that only 2 (5%) of the 40 falls occurred in the dialysis center, whereas 23 (58%) falls 
occurred at home, and 14 (35%) outdoors. Therefore, fall prevention strategies should 
also focus on patient-related factors and the environment at home. By our knowledge, 
no such multifactorial intervention studies in dialysis patients have been reported. Simi-
larly, exercise intervention studies to reduce fall incidents in dialysis patients have not 
been reported. Thus, future studies are needed to identify successful multifactorial and 
exercise interventions that reduce the number of fallers, fall frequency, and fall-related 
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injuries in dialysis patients. Besides, caregivers should have attention for falls, especially 
in the period just after dialysis initiation. 
Acute effects of hemodialysis on the brain
The growing awareness that hemodialysis may carry significant physical costs, extends 
not only to muscle and mobility, but also to the mind. Especially the initiation of hemo-
dialysis does not necessarily improve quality of life,  47 and has been associated with an 
increase in stroke incidence and a decline in cognitive function. 48, 49 This thesis showed 
that hemodialysis induced a decline in global and regional cerebral blood flow in elderly 
patients, which was symptomatic in one patient. This new direct evidence of an acute ef-
fect of the hemodialysis procedure on cerebral blood flow is an important step forwards 
in the understanding of how hemodialysis might induce brain injury. Further research 
is needed to explore whether (repetitive) cerebral blood flow decline are indeed associ-
ated with cognitive decline and cerebral ischemic injury in hemodialysis patients on the 
longer term. 
Furthermore, this thesis showed that a higher tympanic temperature, higher ultrafil-
tration volume and rate, and higher blood pH were associated with lower cerebral blood 
flow. These observations might form a point of departure to develop hemodialysis pro-
tocols that minimize or prevent cerebrovascular stress. It has already been shown that 
lowering the dialysate temperature resulted in an improvement in intradialytic hemody-
namic stability and strongly attenuated the progression of white matter lesions during 
the first year of hemodialysis. 50 A secondary analysis of two dialysis trials, showed that 
more frequent hemodialysis schedules (i.e. 3 versus 6 times a week) with significantly 
lower ultrafiltration volumes in the 6-times group (2.2 vs. 3.1 L/session, and 2.0 vs. 2.5 L/
session) had no impact on cognitive function at 4 and 12 months follow-up. 51 However, 
the beneficial effects of lower ultrafiltration volumes might have been counteracted by 
the more frequent dialysis procedures. Furthermore, patients received cognitive testing 
two to three times within 1 year, which may have induced a learning effect. The presence 
of a learning effect is even likely since cognitive performance improved in both groups. 
Thus, a larger trial with as primary aim to study the effect of lower ultrafiltration volumes 
and, or rates on cognitive function is warranted. Finally, the role of pH in cerebral blood 
flow and cerebral function needs further attention, since this is a modifiable factor by 
changing the dialysate bicarbonate concentration.
Cerebral oxygenation monitoring during hemodialysis 
Cerebral oxygenation is dependent on cerebral blood flow, cerebral blood volume, and 
arterial oxygen content (i.e. the oxygen delivery), and on the cerebral metabolic rate (i.e. 
the oxygen demand). Therefore, the monitoring of cerebral oxygenation might serve 
as a proxy to detect declines in cerebral blood flow during hemodialysis. This thesis 
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showed that the correlation between changes in rSO2, as measured by near-infrared 
spectroscopy, with changes in cerebral blood flow, as measured by PET, was moderate. 
Thus, NIRS could be used as a proxy of PET to detect intradialytic CBF changes, although 
some correction factor may be needed. Furthermore, the different associations of he-
modialysis- and oxygenation-related factors and markers of endothelial activation with 
rSO2 as compared to cerebral blood flow underscore that NIRS and PET capture different 
physiological parameters of the brain. 
Apart from serving as a proxy to detect intradialytic CBF declines, intradialytic near-
infrared spectroscopy monitoring itself might provide clinically relevant information. 
Large rSO2 drops during hemodialysis may have clinical consequences. In our study, four 
patients experienced an rSO2 drop of >20% during hemodialysis. A 20% rSO2 decline has 
been proposed as predictor of cerebral ischemia in patients during carotid endarterec-
tomy and cardiac surgery. 52, 53 Furthermore, a >15% drop in rSO2 during hemodialysis 
was shown to correlate with executive function decline at 1-year follow-up. 54 In future 
studies the long-term effects of a large fall in cerebral oxygenation (e.g. >15-20%) should 
be explored, especially in relation to incident ischemic brain lesions and the long-term 
course of cognitive function. 
Merging the three M’s  
As parts of one body, muscle, mobility and mind are highly interconnected (Figure 1). 
The link between muscles and mobility is evident, and poor muscle strength has 
consistently been identified as one of the main contributors to falls. 55 Vice versa, a fall 
might lead to immobilization, hospitalization, fear of falling, and loss of functional inde-
pendence, all factors that will promote the loss of muscle mass and strength. 
Without the brain there is no mobility. Yet, the influence of the mind on mobility & 
muscle is not limited to neuronal connections between brain and muscle. For example, 
cognitive impairment and dementia are established risk factors for falls. Additionally, 
white matter hyperintensities and loss of white matter integrity, both common in di-
alysis patients, are associated with gait disturbances, mobility and falls. 28-32, 56 Cerebral 
blood flow regulation may play an important role in the connection between mind and 
mobility. It has been suggested that impaired (regional) cerebral blood flow regulation, 
besides promoting cognitive impairment, 57-61 is also associated with alterations in gait 
and development of falls. 62, 63 Besides, endothelial dysfunction and microcirculatory 
damage may explain shared pathology of brain and muscle. Albuminuria, a marker of 
endothelial dysfunction and microcirculatory damage, 64 has been associated with 
cognitive impairment, dementia, 65 and cerebral small vessel disease. 27 Additionally, al-
buminuria has been associated with serious fall injuries, 26 and might even have a direct 
effect on muscle metabolism,  66 and physical performance. 67 
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The opposite direction, namely an effect of mobility and muscle on mind is increas-
ingly getting attention. Indirect evidence is provided by studies that indicate that regu-
lar physical exercise protects against cognitive decline, stroke, and the loss of cerebral 
volume. 68, 69 Furthermore, the benefit of physical activity in depression is generally 
accepted. 70 To understand this connection, it is important to acknowledge the endo-
crine and paracrine function of muscle. 71-73 Muscle-derived secretory proteins, so-called 
‘myokines’, are released upon exercise to ‘communicate’ their energy demands to other 
organs. Several studies suggest myokine secretion as a mechanism behind the beneficial 
effects of exercise on mind. First, exercise led to elevated levels of myokine cathepsin-B, 
which promotes neuroplasticity and increases spatial memory abilities, and correla-
tions were found between patient’s cathepsin-B levels and fitness, and hippocampus-
dependent memory functions. 74 Accordingly, another study indicated that exercise 
promotes neuroplasticity, 75 which is the brains’ ability to reorganize itself by forming 
new neuronal connections throughout life. Third, peroxisome-proliferator-activated re-
ceptor γ coactivator-1α (PGC-1α) proteins in skeletal muscle seem to play an important 





































Figure 1 Merging the three M’s. Connections between Muscle, Mobility and Mind: solid lines represent 
positive effects, whereas dotted lines represent negative effects. The beneficial effects of exercise might 
be mediated by myokines, improvement of endothelial dysfunction and cerebral blood flow regulation. 
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expression of PCG-1α proteins, which are key regulators of mitochondrial biogenesis 
and energy metabolism. 76 A recent study showed that these exercise-induced changes 
in muscle PGC-1α1 favorably affected kynurenine metabolism and thereby protected 
from stress-induced depression. 77 
As a consequence, when considering interventions to improve the three M’s in pa-
tients with advanced chronic kidney disease, it is essential to acknowledge the cross-talk 
between the three M’s and how they influence each other. 
Future directions for improving the three M’s in patients with advanced chronic 
kidney disease
A. Increasing physical activity  
Considering the aforementioned connections between the three M’s, increasing physi-
cal activity and, or physical exercise seems the most obvious intervention to improve 
the 3M’s in patients with chronic kidney disease. In the general population and in the 
chronic kidney disease population many health benefits of physical activity and exercise 
have been demonstrated. The health benefits include, but are not limited to, increases 
in muscle mass and strength, fall reduction, improvements in cognitive functioning, 
increased quality of life, and reduction of systemic inflammation. 78-93 Of note, studies 
even suggest that an increase in muscle mass, or physical activity might slow down the 
kidney disease progression.94-96 Thus, increasing physical activity will potentially yield 
very large health benefits for patients with chronic kidney disease. However, despite the 
robust evidence, most patients are highly inactive and regular physical activity is hardly 
emphasized, encouraged, or prescribed routinely by nephrologists 97, 98 or within dialysis 
clinics. 99-102 
Changing lifestyle is probably one of the most challenging and complex processes. 
Doctors may try to motivate their patients by mentioning all the health benefits of e.g. 
smoking cessation. According Kurt Lewin (1890-1947), an influential psychologist, hu-
man behavior is an equilibrium: “a balance between driving forces that push for change 
and restraining forces that hold back change.” 103 He stated that if you want to achieve 
a change in behavior, it is more efficient to reduce restraining forces, than increase 
driving forces. Translated to medicine, it appears that doctors often try to motivate 
their patients by using the ‘driving forces’ (i.e. arguing all the health benefits), whereas 
addressing the ‘restraining forces’ (e.g. safety concerns, fatigue, comorbidities, or fear 
of pain or falling) might be more effective. Thus, knowledge of the ‘restraining forces’ 
is important. In hemodialysis patients several qualitative studies have been performed 
to explore the barriers to physical activity and exercise. 99, 101, 104-107 Patients mentioned 
that the availability of an individualized intradialytic exercise program that incorporates 
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education and motivation is an important facilitating factor. Besides, patients desired a 
culture of exercise in the dialysis unit. 104 
B. Intradialytic exercise
Since most hemodialysis patients visit the dialysis center three times a week for 4 hours, 
an intradialytic exercise program might be more feasible than participating in a training 
program on non-dialysis days. Besides an increase in muscle mass, muscle strength, and, 
or physical capacity, intradialytic exercise studies also suggested beneficial effects on in-
tradialytic hypotension, bone mineral density, sleep quality, depression symptoms, and 
cognitive functioning. 108-118 Intradialytic exercise interventions that have been studied 
generally consist of aerobic exercise (cycling), or resistance training of some muscular 
groups against elastic bands, or a combination of both. Recently, studies reported on 
the favorable effects of intradialytic respiratory muscle training in hemodialysis patients, 
which were already proven in chronic obstructive pulmonary disease and heart failure 
patients. 119-121 Respiratory muscle training led to significant improvements in pulmo-
nary function, respiratory muscle strength, functional capacity, and quality of life in 
hemodialysis patients, and showed even a greater positive effect on functional capacity 
than peripheral muscle training. 122-126 
In conclusion, the three M’s could be improved by increasing physical activity in patients 
with chronic kidney disease. To achieve lifestyle changes, it might be more efficient to 
focus on the barriers to increase physical activity instead of pushing and arguing on all 
the potential health benefits. In hemodialysis patients, intradialytic exercise programs 
are proven to yield favorable effects on muscle, mobility and mind. Therefore, physical 
training during hemodialysis should be the rule, rather than the exception in dialysis 
clinics. 
C. Nutritional interventions 
Alongside increasing physical activity, optimization of nutritional status and decreasing 
protein energy wasting is warranted in chronic kidney disease patients. In general, pro-
tein supplementation has been shown to be effective for improving markers of protein 
energy wasting. 127 However, there is a paucity of nutritional intervention studies in 
chronic kidney disease, and specifically in dialysis patients. The few studies that were 
performed, among others by the Department of Nephrology in Groningen, showed con-
trasting results on the effect of nutritional supplementation, and protein supplementa-
tion in particular, on muscle mass. 128-133 Besides, it is unclear what the best source is of 
supplemental protein for chronic kidney disease patients with protein energy wasting. 
Thus, studies on nutritional interventions in chronic kidney disease are scarce and the 
evidence for reducing protein energy wasting is inconclusive.  
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d. Bicarbonate supplementation  
Metabolic acidosis stimulates skeletal muscle breakdown, which may be reversed by 
correction of acidosis. 134-136 Studies of bicarbonate supplementation showed improve-
ment of lower extremity muscle strength, and an increase in mid-arm muscle circumfer-
ence in patients with chronic kidney disease. 137, 138 Furthermore, a number of trials are 
in progress that will prospectively measure the effect of bicarbonate therapy on muscle 
and physical function in chronic kidney disease patients.139
Bicarbonate supplementation might particularly be of interest to increase the benefits 
of exercise. In sports medicine, bicarbonate supplementation has been studied for many 
years as a way to enhance athletic performance by e.g. decreasing muscle fatigue. 140 In 
chronic kidney disease patients, exercise could result in transient worsening of acidosis 
through exercise-induced lactate generation, which in turn may reduce the benefits of 
exercise. Therefore, investigators evaluated muscle biopsies after a trial of combined 
walking exercise and standard (target plasma bicarbonate 24 mmol/L) or high bicarbon-
ate (target plasma bicarbonate 29 mmol/L) supplementation in patients with chronic 
kidney disease stage 4-5, not receiving dialysis.141High dose bicarbonate supplementa-
tion resulted in an increase in the circulating bicarbonate concentration, and reduced 
the rise in lactate following acute exercise. Remarkably, muscle biopsies of exercise + 
standard bicarbonate patients showed a depletion of free amino acids after 6 months of 
exercise, whereas muscle biopsies of exercise + high bicarbonate patients did not. 
Since metabolic acidosis leads to neural networks overexcitation and is involved in ce-
rebral autoregulation, researchers hypothesized that serum bicarbonate levels would as-
sociate with cognitive functioning. Indeed, in the Systolic BP Intervention Trial (SPRINT), 
a large cohort of hypertensive adults, higher serum bicarbonate concentration was 
independently associated with better global cognitive and executive performance. 142 
Causality between low bicarbonate and cognitive impairment or whether they just 
share an underlying pathophysiology should be explored in a future longitudinal study. 
Of note, our finding of the association between a higher pH and lower cerebral blood 
flow is not in contrast with the findings of the SPRINT trial. Our study captured the effect 
of an intradialytic pH increase on cerebral blood flow, but this does not automatically 
imply that a higher pH would harm the brain or impair cognitive functioning. 
In conclusion, associations of serum bicarbonate with muscle, physical and cognitive 
functioning have been reported. Future trials should confirm whether bicarbonate 
supplementation or dietary modifications to correct metabolic acidosis consistently 
yield beneficial effects on muscle mass and function in patients with chronic kidney dis-
ease. Besides, bicarbonate supplementation might be needed to enhance the benefits 
of exercise in patients with chronic kidney disease. Insights from sports medicine in the 
effect of bicarbonate supplementation on muscle may be valuable for future research in 
chronic kidney disease. 
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E. Improving endothelial function
Endothelial dysfunction might explain the shared pathology of the brain and muscle in 
chronic kidney disease. The extremely fine-regulated endothelium is the gatekeeper of 
vascular health and has many roles, e.g. regulating the vessel tone. 143 Changes in the 
endothelium are believed to be of primary importance in atherogenesis, the underly-
ing condition in most cardiovascular diseases. Aging, high BMI, smoking, hypertension, 
and metabolic diseases are known risk factors for endothelial dysfunction. 144, 145 Many 
interventions have been suggested or proven to improve endothelial dysfunction, 
which could be categorized into medication (e.g. allopurinol146-148), diet (e.g. magnesium 
supplementation149) or exercise. 150-152 
In chronic kidney disease, the accumulation of uremic toxins contributes to oxidative 
stress and endothelial dysfunction. 153 Besides, hemodialysis is known to (further) induce 
endothelial dysfunction. 154, 155 Several interventions such as intradialytic exercise and 
nocturnal hemodialysis were suggested to attenuate the endothelial dysfunction. Intra-
dialytic cycling led to an increase in serum endothelial progenitor cells, which play a role 
in the regeneration of vascular endothelium. 116 Furthermore, intradialytic respiratory 
muscle training led to a decrease in plasma syndecan-1 (a biomarker of endothelial gly-
cocalyx derangement), and endothelin-1 (a potent vasoconstrictor) concentrations. 123 
Therefore, improvement of endothelial function might be one of the mechanisms by 
which exercise exerts advantageous effects on the three M’s. 
Another option to improve endothelial function is to change the hemodialysis treat-
ment. First, the transition from conventional hemodialysis to nocturnal hemodialysis is 
associated with a significant improvement in endothelial function. 156 Second, online 
hemodiafiltration improves endothelial function, both on the short and long-term, and 
reduces all-cause mortality as compared to conventional hemodialysis. 157-159 It would be 
interesting to study whether nocturnal hemodialysis and hemodiafiltration ultimately 
have relevant advantageous effects on the three M’s as compared to conventional 
hemodialysis. 
F. Closer cooperation between nephrologists and geriatricians in clinical care
Finally, improvement of the three M’s and of the care for geriatric patients with advanced 
chronic kidney disease can be accomplished by a closer cooperation of nephrologists 
and geriatricians. The geriatrician can add specific knowledge and help the nephrologist 
when he or she is faced with patients with geriatric syndromes such as falls, frailty, and 
dementia. As previously mentioned, fall prevention is urgently needed in chronic kidney 
disease and especially in dialysis patient, and geriatricians can provide individualized 
fall prevention advices by a multidisciplinary approach. Furthermore, implementation 
of cognitive screening in advanced chronic kidney disease patients is highly recom-
mended, 160, 161 since clinical awareness of the diagnosis of cognitive impairment was 
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reported to be poor in the dialysis population. 162-164 Identification of cognitive impair-
ment will have clinical implications, because it is associated with greater utilization of 
healthcare resources, decreased quality of life, and with poor outcomes. 165-168 Besides, 
cognitive impairment might also have a major impact on the adherence to medication 
and dietary instructions. Finally, a geriatric assessment can identify geriatric issues that 
nephrologists were not aware of. A comprehensive overview of the geriatric chronic kid-
ney disease patient is crucial, especially when end-stage renal disease approaches and 
the patient face choices regarding renal replacement therapy and treatment modalities.
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In hoofdstuk 1 beschrijven we de achtergrond van dit proefschrift. Wereldwijd en ook 
in Nederland worden we steeds ouder en is de levensverwachting sterk gestegen. Als 
gevolg van de veroudering stijgt ook het vóórkomen van chronische ziekten. Chronisch 
nierfalen, een voorbeeld van een chronische ziekte, komt ook steeds meer voor onder 
ouderen. Daarnaast wordt chronisch nierfalen ook beschouwd als een model van ver-
snelde veroudering. Zowel het chronisch nierfalen zelf, alsook de complicaties van chro-
nisch nierfalen kunnen leiden tot een neerwaartse spiraal van verlies van spiermassa, 
spierfunctie, verlies van fysiek functioneren en van zelfredzaamheid. 
Wanneer de nierfunctie verder verslechtert, ontstaat er eindstadium nierfalen. 
Eindstadium nierfalen kan behandeld worden met nierfunctievervangende therapie, 
bijvoorbeeld in de vorm van hemodialyse (filteren van afvalstoffen uit het bloed via 
een kunstnier in een machine) of peritoneaal dialyse (filteren van afvalstoffen uit het 
bloed via het buikvlies). De start van dialyse kan echter de cognitieve en functionele 
achteruitgang versnellen met vele nadelige gevolgen. Cognitieve achteruitgang heeft 
bijvoorbeeld consequenties voor hoe goed een patiënt alle medicatie kan innemen en 
zich aan een vochtbeperking kan houden. 
Nefrologen zijn dokters die zich bezig houden met de werking van de nieren en met 
nierziekten. Doordat de populatie van patiënten met chronisch nierfalen veroudert, 
moeten nefrologen steeds complexere behandelbeslissingen nemen bij oude patiënten 
met vaak meerdere chronische ziekten en functionele en cognitieve beperkingen. Dit 
is precies waar de nefrologie en geriatrie elkaar raken. Geriaters zijn dokters die zich 
toeleggen op de zorg voor ouderen met meerdere aandoeningen tegelijkertijd, vaak 
een combinatie van lichamelijke, psychische/cognitieve en sociale problemen. Een 
belangrijk aspect is dat de nadruk op herstel of behoud van zelfredzaamheid van de 
oudere patiënt ligt. Het samenbrengen van de expertise van beide specialismen zal voor 
de patiënt van toegevoegde waarde zijn. 
Bij ouderen kan er sprake zijn van zogenaamde ‘geriatrische syndromen’, symptomen 
met meerdere oorzaken die niet passen binnen één ziektecategorie of orgaan. Deze 
geriatrische syndromen, zoals bijvoorbeeld vallen of verwardheid, komen vaak voor bij 
patiënten met chronisch nierfalen en hebben een substantieel negatief effect op de 
kwaliteit van leven. Geriatrische syndromen zijn vaak gerelateerd aan spieren (Muscle), 
mobiliteit (Mobility) en de hersenen (Mind), oftewel de ‘three M’s’. 
Het hoofddoel van dit proefschrift is om chronisch nierfalen vanuit een geriatrisch 
perspectief te bestuderen. In deel I van dit proefschrift  richt de aandacht zich specifiek 
op de spieren, in deel II ligt de focus op mobiliteit en in deel III wordt het effect van he-




deel I - Spieren 
Een lage body mass index (BMI) kan een indicatie zijn voor een lage spiermassa. Een lage 
BMI is gerelateerd aan een slechte overleving in zowel studies van de algemene bevolk-
ing als ook in studies van patiënten met chronische ziekten. Echter in een studie van 
oudere patiënten die gingen starten met dialyse werd geen enkel verband gevonden 
tussen een lage BMI en overleving.  Met name gedurende de eerste periode na start van 
dialyse behandeling is er een verhoogd complicatie- en sterfterisico. Daarom was onze 
hypothese dat het effect van een lage BMI op overleving verschillend zou kunnen zijn op 
de korte termijn vergeleken met de langere termijn na start van dialyse. In hoofdstuk 
2 beschrijven we een studie waarbij we in een cohort van startende dialyse patiënten 
hebben gekeken naar de relatie tussen een lage BMI en sterfte en naar tijdsafhankelijke 
effecten. Onze belangrijkste bevinding was dat een lage BMI op de korte termijn (<1 
jaar na start dialyse) inderdaad een hoger sterfte risico gaf, terwijl op de langere termijn 
(>1 jaar na start dialyse) dit niet meer zo was. Van de patiënten met een lage BMI had-
den degenen die het eerste jaar overleden vaker ook andere chronische ziekten en was 
hun fysieke functioneren slechter vergeleken met de mensen die het eerste jaar wel 
overleefden. 
Vervolgens richtten we ons in een nieuwe studie specifieker op spiermassa bij patiënten 
met chronisch nierfalen. Als maat voor spiermassa gebruikten we de hoeveelheid creati-
nine die aanwezig was in een 24-uurs verzameling van urine. Creatinine is een afbraak-
product van de spieren dat wordt uitgescheiden in de urine. De creatinine uitscheiding 
per 24 uur in de urine weerspiegelt de hoeveelheid spiermassa in het lichaam. In hoofd-
stuk 3 hebben we eerst onderzocht wat referentie waarden zijn voor een normale en 
een lage creatinine concentratie in de urine. Daarvoor hebben we van het PREVEND 
(Prevention of Renal and Vascular End-stage Disease) cohort een subgroep van gezonde 
mensen uit de algemene bevolking geselecteerd en per leeftijdscategorie, geslacht en 
geïndexeerd voor lichaamslengte, de 5e percentiel berekend als ondergrens voor een 
normale creatinine uitscheiding. Vervolgens hebben we deze referentiewaarden toege-
past op een cohort van mensen met chronisch nierfalen, afkomstig uit het PREPARE-2 
(Predialysis Patients Records-2) cohort en uit het NECOSAD (Netherlands Cooperative 
Study on the Adequacy of Dialysis) cohort. We vonden dat 38% van de patiënten met 
chronisch nierfalen een te lage creatinine uitscheiding en dus een te lage spiermassa 
had. Een slechtere nierfunctie, mannelijk geslacht, roken, hartfalen en perifeer vaatli-
jden waren factoren die geassocieerd waren met een lage creatinine uitscheiding bij 
de patiënten met chronisch nierfalen.  Tenslotte hebben we de relatie tussen een lage 
creatinine uitscheiding en zelf-gerapporteerde frailty (kwetsbaarheid) onderzocht. We 
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vonden dat zelf-gerapporteerde frailty gerelateerd was aan een lage creatinine uitschei-
ding, onafhankelijk van eventueel aanwezige comorbiditeit. 
De bevinding dat creatinine excretie gerelateerd was aan zelf-gerapporteerde frailty 
leidde tot ons volgende onderzoek. Onze nieuwe hypothese, die we onderzoeken 
in hoofdstuk 4, was dat creatinine excretie niet alleen een maat voor spiermassa en 
zelf-gerapporteerde frailty, maar ook een maat voor spierkracht zou zijn. In een nieuw 
cohort van dialyse patiënten werd de totale creatinine uitscheiding in het dialysaat en 
in de urine, indien van toepassing, gemeten.  Tevens werden de handknijpkracht en 
enkele zelf-gerapporteerde maten van fysiek functioneren gemeten. We vonden dat 
een hogere creatinine uitscheiding inderdaad geassocieerd was met meer spierkracht 
bij mannen en vrouwen. Ook was een hogere creatinine uitscheiding geassocieerd met, 
volgens zelf-rapportage, beter fysiek functioneren, meer vitaliteit en fysieke activiteit, 
en met minder vermoeidheid en beperkingen door de gezondheid.  Onze conclusie was 
dus dat creatinine excretie de spierkracht en zelf-gerapporteerde fysieke gezondheid 
weerspiegelt bij dialyse patiënten. 
deel II - Mobiliteit
Deel II van het proefschrift richt zich op mobiliteit en in hoofdstuk 5 hebben het ‘ge-
riatrische syndroom’ vallen onderzocht bij dialyse patiënten van 70 jaar en ouder. Ons 
doel was om het optreden van valincidenten, de gevolgen van een val en eventuele risi-
cofactoren voor vallen te onderzoeken in een populatie van oudere dialyse patiënten. 
Gedurende 1 jaar follow-up viel 55% van de patiënten in de studie tenminste 1 keer. De 
valincidenten hadden in 15% van de vallen een botbreuk tot gevolg. Eveneens 15% van 
de vallen leidde tot een opname in het ziekenhuis. Factoren die geassocieerd waren met 
een hoger valrisico waren een lagere systolische bloeddruk voor hemodialyse en een 
hoger bloedwaarde van het bijschildklierhormoon. Deze studie onderstreept dat val-
len een belangrijk probleem is en negatieve gevolgen kan hebben voor oudere dialyse 
patiënten. Preventie studies die meerdere factoren aanpakken, bijvoorbeeld een combi-
natie van patiënteducatie, verbetering van het gezichtsvermogen, medicatie aanpassin-
gen, balansoefeningen en schoeisel, zijn effectief gebleken in het verminderen van het 
aantal vallen en ook de gevolgen van vallen. In de dialysepopulatie is tot nu toe echter 
slechts één preventiestudie gedaan met als doel het aantal vallen te verminderen. Er is 
dus zowel in de klinische praktijk als in het wetenschappelijk onderzoek meer aandacht 
nodig voor vallen en met name naar valpreventie bij dialyse patiënten. 
deel III - Hersenen 
Patiënten met chronisch nierfalen hebben veel vaker cognitieve stoornissen en stem-
mingsstoornissen dan mensen van dezelfde leeftijd maar zonder chronisch nierfalen. 
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Opvallend is dat de start van hemodialyse behandeling geassocieerd is met een ver-
snelde achteruitgang van het cognitief functioneren. Ook is de start van hemodialyse 
behandeling geassocieerd met een toename in het optreden van herseninfarcten 
bij oudere patiënten. Onze hypothese was dat hemodialyse de doorbloeding van de 
hersenen negatief zou kunnen beïnvloeden. Dit is in het verleden al aangetoond voor 
het hart, aangezien hemodialyse tijdelijk de doorbloeding van het hart vermindert. In 
hoofdstuk 6 bespreken we de resultaten van onze studie waarbij we voor, net na start 
en op het einde van een dialysebehandeling de doorbloeding van de hersenen hebben 
gemeten. Om de doorbloeding van de hersenen te meten, gebruikten we de gouden 
standaard methode: een ‘positron emission tomography’ (PET) scan met gebruik van 
radioactief gelabeld water. Aan de studie deden 12 patiënten van 65 jaar en ouder mee. 
Inderdaad vonden we dat hemodialyse leidde tot een afname van de doorbloeding van 
de hersenen met gemiddeld 10%. Zowel in het hele brein, als in de belangrijkste grote 
regio’s van de hersenen zagen we een afname. Hemodialyse-factoren die gerelateerd 
waren aan een lagere hersendoorbloeding waren een hogere pH (zuurgraad) van het 
bloed, een hogere lichaamstemperatuur, en een grotere hoeveelheid vocht die tijdens 
de hemodialyse onttrokken werd. 
Hoewel de ‘water-PET’ de gouden standaard methode is, is het ook een dure en intensieve 
methode om de doorbloeding van de hersenen te meten, zeker tijdens een hemodialyse 
behandeling. Daarom was ons tweede onderzoeksdoel van de ‘PET studie’ om te testen 
of een andere, simpelere meetmethode ook veranderingen in doorbloeding zou de-
tecteren.  Dit onderzoek en de uitkomsten daarvan worden in hoofdstuk 7 beschreven. 
Als simpelere meetmethode hebben we near-infrared spectroscopie onderzocht. 
Near-infrared spectroscopy (NIRS) maakt gebruik van een soort infrarood licht om de 
verhouding tussen zuurstofrijk en zuurstofarm bloed te meten. Deze verhouding tussen 
zuurstofrijk en zuurstofarm bloed geeft een indicatie van de zuurstofverzadiging in het 
weefsel. De zuurstofverzadiging in hersenweefsel is weer afhankelijk van het zuurstof-
gehalte in het bloed, van de hoeveelheid bloed in de hersenen, en van de doorbloeding 
van de hersenen. Tijdens hemodialyse werd de zuurstofverzadiging in een stukje van de 
voorste hersenkwab gemeten met NIRS, tegelijkertijd met de PET metingen. Uit deze 
studie bleek dat de correlatie tussen veranderingen in zuurstofverzadiging (gemeten 
met NIRS) en veranderingen in hersendoorbloeding (gemeten met PET) redelijk goed 
was. De NIRS meting toonde de neiging om de veranderingen in hersendoorbloeding 
systematisch te onderschatten. Daarom zou een zekere correctie factor nodig kunnen 
zijn voor de juiste interpretatie. Daarnaast vonden we dat de relatie van zuurstofverzadig-
ing met verscheidene bloedwaarden op sommige punten sterk verschilde ten opzichte 
van de relatie van hersendoorbloeding met dezelfde verscheidene bloedwaarden. Deze 
uiteenlopende relaties benadrukken dat NIRS en PET twee verschillende fysiologische 
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aspecten van de hersenen meten. Beide meetinstrumenten geven echter belangrijke 
informatie over de hersenen tijdens hemodialyse. NIRS zou als alternatief voor PET 
gebruikt kunnen worden, met de beperking dat NIRS de verandering in doorbloeding 
enigszins lijkt te onderschatten. 
Implicaties voor de praktijk en vervolgonderzoek
Dit proefschrift beschrijft de consequenties van chronisch nierfalen op de ‘three M’s’: 
spieren, mobiliteit en de hersenen. In hoofdstuk 8 hebben we onder andere gekeken 
naar mogelijke implicaties van onze bevindingen voor de praktijk en welk vervolgonder-
zoek er nodig is om de zorg voor patiënten met chronisch nierfalen verder te verbeteren. 
Allereerst zou creatinine uitscheiding als maat voor spiermassa, spierfunctie, frailty 
en fysiek functioneren beter benut kunnen worden. De creatinine uitscheiding wordt 
namelijk al bepaald in de klinische praktijk. Bij patiënten die nog niet dialyseren, wordt 
met regelmaat de creatinine uitscheiding in de 24-uurs urine gemeten om nauwkeurig 
de nierfunctie te kunnen berekenen. Bij patiënten die door middel van buikspoeling 
dialyseren, wordt ook met regelmaat de creatinine uitscheiding in het dialysaat en 
de urine, indien van toepassing, gemeten. En bij hemodialyse patiënten zou ook vrij 
gemakkelijk een dialysaatmonster genomen kunnen worden tijdens de hemodialyse 
om de creatinine uitscheiding te bepalen. Het monitoren van de creatinine excretie 
kan veel informatie geven. Een daling van de creatinine uitscheiding zou een teken 
kunnen zijn van spiermassa en spierfunctie achteruitgang en verdient aandacht van de 
nefroloog. Verder onderzoek moet uitwijzen of een daling in creatinine uitscheiding ook 
met slechte uitkomsten geassocieerd is, en of bijvoorbeeld een trainingsprogramma en 
extra aandacht voor de voeding het proces dan kunnen keren. 
Dit proefschrift laat zien dat vallen een veel voorkomend probleem is bij oudere dialy-
sepatiënten. Ander onderzoek laat zien dat met name de periode net na start van dialyse 
een hoog-risico periode is waarbij patiënten een nog hogere kans hebben om te vallen. 
Daarom verdient dit ‘geriatrische syndroom’ meer aandacht van dialyse behandelteams, 
zeker net na start van dialyse. Een val is vaak het begin van een neerwaartse spiraal van 
verminderd functioneren, verlies van kwaliteit aan leven, en leidt zelfs tot een verhoogd 
sterfterisico. Er is meer wetenschappelijk onderzoek nodig naar specifieke interventies 
die het aantal vallen en de gevolgen van vallen bij dialysepatiënten succesvol kunnen 
terugdringen. En niet alleen dialysepatiënten hebben een hoog valrisico, ook patiënten 
met een nog milder stadium van chronisch nierfalen hebben al een verhoogd valrisico. 
Dus ook in deze patiëntengroep is meer aandacht voor vallen nodig.
Hemodialyse behandeling kan behalve het gunstige levensverlengende effect ook 
nadelen hebben. Zo is verlies van zelfredzaamheid na de start van dialyse beschreven, 
evenals een versnelde achteruitgang van cognitief functioneren en een toename van 
schade in de hersenen. Dit proefschrift laat zien dat hemodialyse leidt tot een afname 
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in de doorbloeding van de hersenen. De afname in doorbloeding zou een verklaring 
kunnen zijn van de nadelige effecten die het starten van hemodialyse op de hersenen 
heeft. De bevindingen van ons onderzoek kunnen een aanknopingspunt vormen voor 
toekomstig onderzoek, bijvoorbeeld naar het verlagen van de hoeveelheid vocht die 
onttrokken wordt, en of de snelheid waarmee het vocht onttrokken wordt tijdens 
hemodialyse. Voor toekomstig onderzoek kan NIRS gebruikt worden om de zuurstofver-
zadiging van de hersenen te monitoren tijdens hemodialyse. Een daling in zuurstofver-
zadiging kan het gevolg zijn van een daling in doorbloeding van de hersenen. Ander 
onderzoek heeft laten zien dat een >15% daling in zuurstofverzadiging geassocieerd 
was met een afname in cognitief functioneren op de lange termijn. NIRS biedt dus zeker 
perspectief voor verder onderzoek naar de effecten van hemodialyse op de hersenen en 













































Figuur 1 Connecties tussen spieren, mobiliteit en de hersenen. De niet-onderbroken pijlen geven een posi-
tief effect aan en de onderbroken pijlen geven een negatief effect aan.  
De ‘three M’s’, namelijk spieren, mobiliteit en hersenen, zijn onderling sterk verbonden 
(zie Figuur 1). Onze hersenen sturen de spieren aan, die we weer nodig hebben voor 
mobiliteit en beweging. Anderzijds kan een val leiden tot een botbreuk, immobilisatie 
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en spiermassaverlies. Bovendien blijken beschadigingen in de hersenen gerelateerd 
te zijn aan een slechtere mobiliteit in de vorm van een tragere loopsnelheid en een 
minder goed evenwicht. De regulatie van de hersendoorbloeding speelt hier mogelijk 
een belangrijke rol bij. Het belang van fysieke activiteit voor het goed functioneren van 
de hersenen krijgt steeds meer aandacht. Veel studies laten zien dat regelmatig bewe-
gen bescherming biedt tegen cognitieve achteruitgang, depressie, een herseninfarct 
en verlies van hersenweefsel. Deze gunstige effecten zullen ook de kwaliteit van leven 
positief beïnvloeden. 
Om de ‘three M’s’ bij patiënten met chronisch nierfalen te verbeteren danwel de func-
tie zoveel mogelijk te behouden, zijn verschillende interventies denkbaar. In het tweede 
deel van hoofdstuk 8 worden verschillende mogelijkheden geschetst, zoals een fysiek 
actievere leefstijl, bewegen tijdens hemodialyse behandeling, bicarbonaatsuppletie, en 
een intensievere samenwerking tussen geriaters en nefrologen. Dit proefschrift vormt 
hopelijk een stimulans voor deze intensievere samenwerking met als uiteindelijke doel 
verbetering van kwaliteit van leven van de (oudere) patiënt met chronisch nierfalen.  

